Literature DB >> 25945971

DEK over-expression promotes mitotic defects and micronucleus formation.

Marie C Matrka1, Robert F Hennigan1, Ferdinand Kappes2,3, Monica L DeLay4, Paul F Lambert5, Bruce J Aronow6, Susanne I Wells1.   

Abstract

The DEK gene encodes a nuclear protein that binds chromatin and is involved in various fundamental nuclear processes including transcription, RNA splicing, DNA replication and DNA repair. Several cancer types characteristically over-express DEK at the earliest stages of transformation. In order to explore relevant mechanisms whereby DEK supports oncogenicity, we utilized cancer databases to identify gene transcripts whose expression patterns are tightly correlated with that of DEK. We identified an enrichment of genes involved in mitosis and thus investigated the regulation and possible function of DEK in cell division. Immunofluorescence analyses revealed that DEK dissociates from DNA in early prophase and re-associates with DNA during telophase in human keratinocytes. Mitotic cell populations displayed a sharp reduction in DEK protein levels compared to the corresponding interphase population, suggesting DEK may be degraded or otherwise removed from the cell prior to mitosis. Interestingly, DEK overexpression stimulated its own aberrant association with chromatin throughout mitosis. Furthermore, DEK co-localized with anaphase bridges, chromosome fragments, and micronuclei, suggesting a specific association with mitotically defective chromosomes. We found that DEK over-expression in both non-transformed and transformed cells is sufficient to stimulate micronucleus formation. These data support a model wherein normal chromosomal clearance of DEK is required for maintenance of high fidelity cell division and chromosomal integrity. Therefore, the overexpression of DEK and its incomplete removal from mitotic chromosomes promotes genomic instability through the generation of genetically abnormal daughter cells. Consequently, DEK over-expression may be involved in the initial steps of developing oncogenic mutations in cells leading to cancer initiation.

Entities:  

Keywords:  DEK; aneuploidy; cancer; chromosome instability; micronuclei; mitosis; mitotic defects

Mesh:

Substances:

Year:  2015        PMID: 25945971      PMCID: PMC4825741          DOI: 10.1080/15384101.2015.1044177

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  72 in total

1.  Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.

Authors:  Mónica Campillos; Miguel Angel García; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

2.  Micronucleus investigation of alcoholic patients with oral carcinomas.

Authors:  Andréa Ramirez; Pedro Henrique Saldanha
Journal:  Genet Mol Res       Date:  2002-09-30

Review 3.  Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion gene.

Authors:  M von Lindern; M Fornerod; N Soekarman; S van Baal; M Jaegle; A Hagemeijer; D Bootsma; G Grosveld
Journal:  Baillieres Clin Haematol       Date:  1992-10

4.  Homologous recombination proteins are associated with centrosomes and are required for mitotic stability.

Authors:  Enrico Cappelli; Stuart Townsend; Carol Griffin; John Thacker
Journal:  Exp Cell Res       Date:  2011-01-27       Impact factor: 3.905

Review 5.  Cytokinesis-block micronucleus assay evolves into a "cytome" assay of chromosomal instability, mitotic dysfunction and cell death.

Authors:  Michael Fenech
Journal:  Mutat Res       Date:  2006-07-05       Impact factor: 2.433

6.  Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene.

Authors:  Morgan Sammons; Shan Shan Wan; Nancy L Vogel; Edwin J Mientjes; Gerard Grosveld; Brian P Ashburner
Journal:  J Biol Chem       Date:  2006-07-07       Impact factor: 5.157

7.  Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements.

Authors:  M Fornerod; J Boer; S van Baal; M Jaeglé; M von Lindern; K G Murti; D Davis; J Bonten; A Buijs; G Grosveld
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

8.  DNA damage signaling in response to double-strand breaks during mitosis.

Authors:  Simona Giunta; Rimma Belotserkovskaya; Stephen P Jackson
Journal:  J Cell Biol       Date:  2010-07-26       Impact factor: 10.539

9.  DEK proto-oncogene expression interferes with the normal epithelial differentiation program.

Authors:  Trisha M Wise-Draper; Richard J Morreale; Teresa A Morris; Rachael A Mintz-Cole; Elizabeth E Hoskins; Scott J Balsitis; Nader Husseinzadeh; David P Witte; Kathryn A Wikenheiser-Brokamp; Paul F Lambert; Susanne I Wells
Journal:  Am J Pathol       Date:  2008-11-26       Impact factor: 4.307

Review 10.  Aneuploidy and cancer.

Authors:  Harith Rajagopalan; Christoph Lengauer
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  8 in total

1.  The nuclear DEK interactome supports multi-functionality.

Authors:  Eric A Smith; Eric F Krumpelbeck; Anil G Jegga; Malte Prell; Marie M Matrka; Ferdinand Kappes; Kenneth D Greis; Abdullah M Ali; Amom R Meetei; Susanne I Wells
Journal:  Proteins       Date:  2017-11-11

2.  MicroRNA-1292-5p inhibits cell growth, migration and invasion of gastric carcinoma by targeting DEK.

Authors:  Wentao Hui; Xiaobin Ma; Ying Zan; Lingqin Song; Shuqun Zhang; Lei Dong
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

3.  KDM4C Activity Modulates Cell Proliferation and Chromosome Segregation in Triple-Negative Breast Cancer.

Authors:  Jeison Garcia; Fernando Lizcano
Journal:  Breast Cancer (Auckl)       Date:  2016-11-02

4.  Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis.

Authors:  Marie C Matrka; Miki Watanabe; Ranjithmenon Muraleedharan; Paul F Lambert; Andrew N Lane; Lindsey E Romick-Rosendale; Susanne I Wells
Journal:  PLoS One       Date:  2017-05-30       Impact factor: 3.240

5.  DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma.

Authors:  Eric A Smith; Bhavna Kumar; Kakajan Komurov; Stephen M Smith; Nicole V Brown; Songzhu Zhao; Pawan Kumar; Theodoros N Teknos; Susanne I Wells
Journal:  Oncotarget       Date:  2017-04-04

6.  DEK is required for homologous recombination repair of DNA breaks.

Authors:  Eric A Smith; Boris Gole; Nicholas A Willis; Rebeca Soria; Linda M Starnes; Eric F Krumpelbeck; Anil G Jegga; Abdullah M Ali; Haihong Guo; Amom R Meetei; Paul R Andreassen; Ferdinand Kappes; Lisa M Privette Vinnedge; Jeremy A Daniel; Ralph Scully; Lisa Wiesmüller; Susanne I Wells
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

7.  Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.

Authors:  Marie C Matrka; Katherine A Cimperman; Sarah R Haas; Geraldine Guasch; Lisa A Ehrman; Ronald R Waclaw; Kakajan Komurov; Adam Lane; Kathryn A Wikenheiser-Brokamp; Susanne I Wells
Journal:  PLoS Genet       Date:  2018-03-14       Impact factor: 5.917

8.  Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2.

Authors:  Emrah Özçelik; Ahmet Kalaycı; Büşra Çelik; Açelya Avcı; Hasan Akyol; İrfan Baki Kılıç; Türkan Güzel; Metin Çetin; Merve Tuzlakoğlu Öztürk; Zihni Onur Çalışkaner; Melike Tombaz; Dilan Yoleri; Özlen Konu; Ayten Kandilci
Journal:  PLoS One       Date:  2022-10-03       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.